Metabolism Disorder TRIZ Cases

Triazole-linked insulin-incretin conjugates merge glucose-lowering and appetite-suppressing functions to reduce hypoglycemia risk.

Novel C-domain design eliminates microcrystalline suspensions to resolve manufacturing complexity and dosing precision trade-offs.

Modified pectin gelates in acidic environments to prevent diarrhea, resolving the contradiction between efficacy and storage stability.

Modulating follistatin activity increases UCP-1 protein levels to promote brown adipose tissue differentiation, addressing obesity treatment limitations.

Copolyamino acids stabilize injectable human glucagon, preventing fibril formation and degradation at physiological pH.

Bovine leukemia virus receptor-binding domain binds specifically to the cationic amino acid transporter CAT1.

A bilayer aspirin tablet design delivers rapid intraoral and sustained gastrointestinal release profiles to manage niacin therapy.

Three-dimensional culture systems generate hepatocyte-like cells from adipocyte-derived stem cells using specific growth factors.

A GCGR antibody fused with GLP-1 lowers blood sugar levels through synergistic receptor interaction.

Anti-IL-20 antibody mAb 7E reduces bone loss by inhibiting RANKL expression, addressing inadequate inflammatory pathway management in rheumatoid arthritis.

A long-acting insulin administration regime determines dosage using a single fasting blood glucose measurement.

A zwitterionic polymer conjugated with insulin and saccharide moieties enables controlled release of the hormone.

Chemically modified alginates reduce fibrous capsule formation and inflammatory responses on implanted devices.

Engineered human alpha-galactosidase polypeptides resolve enzyme instability and poor cellular uptake in Fabry disease treatments.

Optimized pH 7.8-9.0 buffers prevent fibrillation and oxidation in therapeutic peptide solutions.

Combining abscisic acid with thiazolidinediones activates PPAR gamma receptors to improve insulin sensitivity.

A system measures nutrient levels and calculates intake to produce personalized compositions via 3D printing.

A RIP2 kinase inhibitor prodrug converts into an active therapeutic agent to enhance oral bioavailability.

Cyclic fasting mimicking diet lowers blood glucose and IGF-1 levels while preserving muscle mass via segmented caloric protocols.

Peptidomimetic neurokinin B antagonists delay fish maturation by blocking tac-3 receptors, resolving the trade-off between reproductive timing and growth rates.

Ketone supplements shift systemic metabolism to reduce insulin and IGF-1 levels, addressing root causes of age-related conditions.

Optimized zilpaterol hydrochloride dosing overcomes reduced responsiveness in rapidly growing broiler strains, improving carcass yield.

A transdermal device delivers brain energy molecules through skin permeation enhancers to maintain glucose levels during sleep.

A Streptococcus australis composition reduces fasting blood glucose levels and improves glucose tolerance in subjects with metabolic disorders.

Neutralizing FGF-23 with antibodies reduces phosphate excretion, lowering dietary supplementation costs and environmental contamination.

An optimized PAH gene expression cassette enables stable protein production in the liver.

A tri-blend HPMC and myristic fatty acid composition elevates plasma adiponectin levels.

Nested sleeves and covers shield slit boundaries against transverse pulling forces to prevent splitting.

Poloxamer prevents enzyme precipitation during infusion, maintaining therapeutic efficacy.

Combines metformin with taurine, citrulline, and methylcobalamin to offset antioxidant-induced potency loss.

Maleimide-linked antibody-drug conjugate targets cancer cells, reducing systemic cytotoxicity and side effects.

Asimina triloba extract replaces synthetic drugs to resolve the contradiction between anti-obesity effectiveness and harmful side effects.

Modifying the N-terminal histidine residue of exendin-4 increases resistance to dipeptidyl peptidase degradation while maintaining receptor affinity.